Corrigendum to "Avasimibe can cooperate with a DC-targeting and integration-deficient lentivector to induce stronger HBV specific T cytotoxic response by regulating cholesterol metabolism" Antiviral Res. 2023 Aug:216:105662
| Errataetall: |
ErratumFor: Antiviral Res. 2023 Aug;216:105662. - PMID 37393054 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:225 |
|---|---|
| Enthalten in: |
Antiviral research - 225(2024) vom: 20. Apr., Seite 105860 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ma, Siyuan [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 17.04.2024 published: Print-Electronic ErratumFor: Antiviral Res. 2023 Aug;216:105662. - PMID 37393054 Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.antiviral.2024.105860 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM369984854 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM369984854 | ||
| 003 | DE-627 | ||
| 005 | 20240418232817.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240322s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.antiviral.2024.105860 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1379.xml |
| 035 | |a (DE-627)NLM369984854 | ||
| 035 | |a (NLM)38508907 | ||
| 035 | |a (PII)S0166-3542(24)00069-X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ma, Siyuan |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Corrigendum to "Avasimibe can cooperate with a DC-targeting and integration-deficient lentivector to induce stronger HBV specific T cytotoxic response by regulating cholesterol metabolism" Antiviral Res. 2023 Aug:216:105662 |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 17.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a ErratumFor: Antiviral Res. 2023 Aug;216:105662. - PMID 37393054 | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 650 | 4 | |a Published Erratum | |
| 700 | 1 | |a Lv, Mengjiao |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Xiaohua |e verfasserin |4 aut | |
| 700 | 1 | |a Zang, Guoqing |e verfasserin |4 aut | |
| 700 | 1 | |a Tang, Zhenghao |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Yi |e verfasserin |4 aut | |
| 700 | 1 | |a Hu, Weiwei |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Antiviral research |d 1983 |g 225(2024) vom: 20. Apr., Seite 105860 |w (DE-627)NLM012601756 |x 1872-9096 |7 nnns |
| 773 | 1 | 8 | |g volume:225 |g year:2024 |g day:20 |g month:04 |g pages:105860 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.antiviral.2024.105860 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 225 |j 2024 |b 20 |c 04 |h 105860 | ||